InsiderFlow

Benjamin Hohl

ELVN

Benjamin Hohl serves as officer: CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

36 trades

$3.27M

Net Position

Net Seller

$3.27M

Companies Traded

1

ELVN

Active Period

Dec 2023 – Mar 2026

36 total trades

Most Recent

Sell ELVN

Mar 10, 2026 · $295.8K

Benjamin Hohl's Insider Trading at Enliven Therapeutics, Inc. (ELVN)

Buys

0 · $0.00

Sells

36 · $3.27M

Total Shares Bought

0

Total Shares Sold

144,064

ELVN Price Chart
Loading chart...
DateTypeValue
Mar 10, 2026 Sell$295.8K
Sep 29, 2025 Sell$66.3K
Aug 27, 2025 Sell$67.0K
Jul 28, 2025 Sell$66.5K
Jul 10, 2025 Sell$22.7K
Jun 27, 2025 Sell$68.0K
Jun 13, 2025 Sell$67.7K
May 27, 2025 Sell$52.6K
Apr 28, 2025 Sell$60.7K
Mar 27, 2025 Sell$69.3K
Mar 24, 2025 Sell$22.5K
Feb 27, 2025 Sell$66.3K
Feb 5, 2025 Sell$22.5K
Jan 27, 2025 Sell$70.2K
Dec 27, 2024 Sell$94.5K
Dec 13, 2024 Sell$25.0K
Nov 27, 2024 Sell$130.7K
Oct 28, 2024 Sell$178.5K
Oct 18, 2024 Sell$24.4K
Oct 4, 2024 Sell$316.0K
Oct 1, 2024 Sell$14.3K
Sep 27, 2024 Sell$153.8K
Aug 27, 2024 Sell$95.8K
Jul 31, 2024 Sell$27.3K
Jul 29, 2024 Sell$140.1K
Jul 12, 2024 Sell$75.2K
Jun 27, 2024 Sell$95.9K
May 28, 2024 Sell$98.5K
May 3, 2024 Sell$22.5K
Apr 29, 2024 Sell$55.2K
Apr 11, 2024 Sell$346.1K
Mar 27, 2024 Sell$59.3K
Feb 27, 2024 Sell$55.2K
Jan 29, 2024 Sell$51.4K
Dec 28, 2023 Sell$178.3K
Dec 22, 2023 Sell$17.0K